PTEN Mutations: Cancer Risks
Cancer Risks Associated with Inherited Mutations
People with an inherited have an increased lifetime risk of developing several types of cancer. A person with a mutation has about an 85% chance for developing any type of cancer in their lifetime. The risks for cancer tend to happen at a younger age compared to people who do not have a mutation.
If you have tested positive for an inherited mutation, we recommend that you speak with a genetics expert who can look at your personal and family history of cancer and help you decide on a plan for managing your cancer risk.
It is important to note that cancer risks are estimates over the course of a person's lifetime. Your risk will vary, depending on your:
- current age.
- sex assigned at birth.
- specific mutation.
- personal and family health history.
- diet, exercise, lifestyle and other factors.
|
Cancer Type |
Risk to Age 80 with a Mutation |
Lifetime Risk for General Population |
|
Breast cancer |
40% - 60% |
12.5% |
|
28% |
3.1% |
|
|
Thyroid cancer (and benign thyroid growths) |
35% |
1% |
|
Kidney cancer |
34% |
1 - 2% |
|
Colorectal |
9 - 20% |
2.4% |
|
Melanoma |
6% |
2.5% |
|
Sources: NCCN Guidelines: Genetic/Familial High-Risk Assessment: Breast, Ovarian, Pancreatic, and Prostate; v.1 2027; NCCN Guidelines: Genetic/Familiar High-Risk Assessment: Colorectal, Endometrial, Esophageal, and Gastric; v.1 2026. |
||
May 29, 2026
Written by Rebekah Wells on behalf of FORCE One mother and her adult daughters share what they learned—and what they wish they’d known—about navigating genetic testing and learning about their inherited PTEN...
Find Compassionate Support
Making treatment decisions may feel overwhelming or isolating. You don't have to face this alone. Find support from people who have been there and understand.
Get Help Locating Resources
Connect with a trained volunteer who can help you navigate the decisions you face about hereditary cancer or cancer risk.
Learn More About Hereditary Cancers
Visit our section with in-depth information on screening, prevention or treatment of different types of cancer.